CMS Proposes National Noncoverage Of VNS Therapy For Depression

CMS plans to reject Cyberonics' request for national Medicare coverage of its VNS therapy for treatment-resistant depression, an action that would also end the firm's ability to seek coverage from local Medicare carriers

More from Archive

More from Medtech Insight